The study, led by Professor Foulds, took place over 24 weeks in Pennsylvania at Penn State Medical Center and in Virginia at the University of Richmond.
The 520 participants were randomly divided into 4 groups in a double-blind way.
- A group of 130 people formed a placebo group with the use of a cigarette-shaped tube.
- A group of 130 participants received an eGo electronic cigarette containing a nicotine-free e-liquid.
- A third group used a nicotine level of 8mg/ml.
- The last group was given an e-cigarette with an e-liquid of 36mg/ml.
The study did not set out to investigate potential smoking cessation in the participants, but only to calculate the number of cigarettes smoked in parallel with the device and the level of carbon monoxide exhaled, with check-ups during regular visits over the course of 24 weeks.
After 6 months, the study results were surprising. In the group of 130 participants who received an e-liquid containing 36mg of nicotine, 10.8% of the participants in this group had spontaneously stopped smoking. This drops to 4.6% for the 8mg/ml group and 0.8% among the participants who received 0mg of nicotine.
What can we learn from this study ?